SLRX

Salarius Pharmaceuticals Inc

NASDAQ: SLRX · HEALTHCARE · BIOTECHNOLOGY

$0.84

+29.23% today

Updated 2026-01-07

Market cap

$4.92M

P/E ratio

—

P/S ratio

18.12x

EPS (TTM)

$-24.24

Dividend yield

—

52W range

$1 – $25

Volume

2.4M

Market cap

$4.92M

P/E ratio

—

P/S ratio

18.12x

EPS (TTM)

$-24.24

Dividend yield

—

52W range

$1 – $25

Volume

2.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$26.00

+2995.24%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-1.65M

- Revenue declining -1.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$1.84M	$0.00	$0.00	$0.00	$0.00
Net income	$-12.77M	$-31.61M	$-12.54M	$-5.58M	$-873467.00
EPS	—	—	—	—	$-24.24
Free cash flow	$-10.20M	$-19.10M	$-12.85M	$-4.53M	$-1.65M
Profit margin	-693.84%	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
SLRX	$4.92M	21	3.7	3.0	5.0	5.0	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Salarius Pharmaceuticals Inc trades at $0.84. Our Smart Value Score of 21/100 indicates the stock is weak.

Frequently asked questions

What is Salarius Pharmaceuticals Inc's stock price?

Salarius Pharmaceuticals Inc (SLRX) trades at $0.84, on a P/S of 18.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.

Is Salarius Pharmaceuticals Inc overvalued?

Salarius Pharmaceuticals Inc carries a Smart Value Score of 21/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Salarius Pharmaceuticals Inc (SLRX)?

The 12-month analyst consensus target is $26.00, about 2995.2% above the current $0.84. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio18.12x

ROE-1.40%

Beta0.32

50D MA$0.82

200D MA$6.61

Shares out0.01B

Float0.01B

Short ratio—

Avg volume2.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

SLRX vs LLY →SLRX vs JNJ →SLRX vs ABBV →Stock screener →